Maccarrone M et al. |
Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. |
2002 |
Blood |
pmid:12393387
|
González S et al. |
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. |
2002 |
Brain Res. |
pmid:12393235
|
Milton NG |
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. |
2002 |
Neurosci. Lett. |
pmid:12384227
|
Barthó L et al. |
Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. |
2002 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:12382081
|
Roberts LA et al. |
Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. |
2002 |
Br. J. Pharmacol. |
pmid:12359623
|
Wallace MJ et al. |
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. |
2002 |
Eur. J. Pharmacol. |
pmid:12359270
|
Laine K et al. |
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. |
2002 |
Invest. Ophthalmol. Vis. Sci. |
pmid:12356827
|
Ralevic V et al. |
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. |
2002 |
Life Sci. |
pmid:12354577
|
Oz M et al. |
Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. |
2002 |
Synapse |
pmid:12325042
|
Kozak KR et al. |
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. |
2002 |
J. Biol. Chem. |
pmid:12244105
|
Schuel H et al. |
Evidence that anandamide-signaling regulates human sperm functions required for fertilization. |
2002 |
Mol. Reprod. Dev. |
pmid:12237954
|
Rueda D et al. |
The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. |
2002 |
J. Biol. Chem. |
pmid:12237305
|
Anikwue R et al. |
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12235269
|
Burstein SH et al. |
Regulation of anandamide tissue levels by N-arachidonylglycine. |
2002 |
Biochem. Pharmacol. |
pmid:12234618
|
Plant LD et al. |
Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. |
2002 |
Stroke |
pmid:12215606
|
Someya A et al. |
Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells. |
2002 |
Eur. J. Pharmacol. |
pmid:12206851
|
Kagaya M et al. |
Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. |
2002 |
Br. J. Pharmacol. |
pmid:12183329
|
Randall MD et al. |
Cardiovascular effects of cannabinoids. |
2002 |
Pharmacol. Ther. |
pmid:12182966
|
Hansen HS et al. |
Putative neuroprotective actions of N-acyl-ethanolamines. |
2002 |
Pharmacol. Ther. |
pmid:12182959
|
Goutopoulos A and Makriyannis A |
From cannabis to cannabinergics: new therapeutic opportunities. |
2002 |
Pharmacol. Ther. |
pmid:12182958
|
Andersson DA et al. |
Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. |
2002 |
Mol. Pharmacol. |
pmid:12181448
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Chemin J et al. |
Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. |
2002 |
J. Neurosci. |
pmid:12177183
|
van der Stelt M et al. |
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. |
2002 |
J. Med. Chem. |
pmid:12166944
|
Barnett-Norris J et al. |
Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. |
2002 |
J. Med. Chem. |
pmid:12166938
|
de Lago E et al. |
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:12163112
|
Costa B et al. |
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. |
2002 |
Eur. J. Pharmacol. |
pmid:12163107
|
Schäbitz WR et al. |
Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. |
2002 |
Stroke |
pmid:12154273
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
Habayeb OM et al. |
Endogenous cannabinoids: metabolism and their role in reproduction. |
2002 |
Life Sci. |
pmid:12148689
|
Di Marzo V et al. |
Endovanilloid signaling in pain. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12139983
|
Liu WM et al. |
Effects of anandamide on embryo implantation in the mouse. |
2002 |
Life Sci. |
pmid:12137909
|
Dinh TP et al. |
Brain monoglyceride lipase participating in endocannabinoid inactivation. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12136125
|
Szallasi A |
Vanilloid (capsaicin) receptors in health and disease. |
2002 |
Am. J. Clin. Pathol. |
pmid:12109845
|
Sugiura T and Waku K |
Cannabinoid receptors and their endogenous ligands. |
2002 |
J. Biochem. |
pmid:12097154
|
Vinklerová J et al. |
Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. |
2002 |
J. Psychopharmacol. (Oxford) |
pmid:12095072
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Di Marzo V et al. |
Anandamide receptors. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052051
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Pinto L et al. |
Endocannabinoids and the gut. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052047
|
Fride E |
Endocannabinoids in the central nervous system--an overview. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052038
|
Deutsch DG et al. |
The fatty acid amide hydrolase (FAAH). |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052036
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Mechoulam R |
Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052029
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Williams CM and Kirkham TC |
Observational analysis of feeding induced by Delta9-THC and anandamide. |
2002 |
Physiol. Behav. |
pmid:12044596
|
Farquhar-Smith WP et al. |
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. |
2002 |
Pain |
pmid:12031775
|
Smart D et al. |
'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. |
2002 |
Br. J. Pharmacol. |
pmid:12023948
|
Porter AC et al. |
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12023533
|